|
Κυριακή 13 Δεκεμβρίου 2020
A Phase 1 study of RO6870810, a novel bromodomain and extra-terminal protein inhibitor, in patients with NUT carcinoma, other solid tumours, or diffuse large B-cell lymphoma
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Related Articles Medical Management of Chronic Rhinosinusitis - A review of traditional and novel medical therapies. Expert Opin Inve...
-
Abstract Purpose Traumatic subclavian vascular injury (TSVI) is rare but often fatal. The precise diagnosis of TSVI remains challenging ...
-
Abstract A crucial step in the infection process of grazing ruminants by gastro-intestinal nematodes is the exsheathment of the infective ...
-
Related Articles Can You Hear Me Now? Marketing Essentials for Audiologists in a Noisy Health Care World. Semin Hear. 2016 Nov;37(4):...
-
Editorial AJR Reviewers: Heartfelt Thanks From the Editors and Staff Thomas H. Berquist 1 Share + Affiliation: Citation: American Journal...
-
Semen quality and cigarette smoking in a cohort of healthy fertile men Background: Numerous health effects of smoking are well-known; associ...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου